Although CD44+/CD24- cells were regarded as breast CSCs and to be linked with poor prognosis in some breast cancer patients, the association between these cells and tumor recurrence or metastasis in all or some patients with breast cancer, especially those with invasive ductal carcinoma, has been unclear. Here, CD44 is linked to invasive ductal breast carcinoma.